Velcade Prescribing & Dosing Schedule

Dosage & Administration Drug label Financial assistance Patient education People also ask

Velcade (bortezomib)

VELCADE 3.5 MG Injection

NO BOXED WARNING

Dosage & Administration

* For subcutaneous or intravenous use only. Each route of administration has a different reconstituted concentration. Exercise caution when calculating the volume to be administered.
* The recommended starting dose of VELCADE is 1.3 mg/m2 administered either as a 3 to 5 second bolus intravenous injection or subcutaneous injection.
* Retreatment for Multiple Myeloma: May retreat starting at the last tolerated dose.
* Hepatic Impairment: Use a lower starting dose for patients with moderate or severe hepatic impairment.
* Dose must be individualized to prevent overdose.

drug label

Velcade Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

financial assistance

Velcade Financial Assistance Options

Foundation programs

Velcade Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.